| 产品描述: | Ganaplacide (KAF156) hydrochloride is a first-in-class, orally active imidazolopiperazine antimalarial agent. Ganaplacide hydrochloride is active against a broad range of Plasmodium species, including drug-resistant parasites. Ganaplacide hydrochloride is parasiticidal against both asexual and sexual blood stages as well as the liver stages of the parasite. |
| 靶点: |
Plasmodium |
| 体外研究: |
KAF156 对成熟的恶性疟原虫 配子体表现出杀灭活性,从而阻止寄生虫传播给按蚊蚊子[1]。 Ganaplacide hydrochloride (KAF156) hydrochloride (1-15 mg/kg;口服) 在疟疾的因果预防小鼠模型中具有充分的保护作用[1]。 |
| 体内研究: |
Ganaplacide hydrochloride (KAF156) hydrochloride 显示出血液裂殖体杀活性,针对 P. falciparum 药物敏感和耐药菌株的 50% 抑制浓度为 6 至 17.4 nM。 |
| 参考文献: |
1. Kuhen KL, et al. KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission. Antimicrob Agents Chemother. 2014;58(9):5060-5067. 2. Leong FJ, et al. A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers. Antimicrob Agents Chemother. 2014;58(11):6437-6443. |
| 保存条件: |
-80°C 12个月; -20°C 6个月, 干燥 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.233 ml |
11.163 ml |
22.326 ml |
| 5 mM |
0.447 ml |
2.233 ml |
4.465 ml |
| 10 mM |
0.223 ml |
1.116 ml |
2.233 ml |
| 50 mM |
0.045 ml |
0.223 ml |
0.447 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |